期刊文献+

化生性乳腺癌23例临床分析 被引量:1

原文传递
导出
摘要 化生性乳腺癌是一类罕见的乳房恶性肿瘤,其发病率约占所有类型乳腺癌的0.02% ~ 1%.我院自2001-2011年收治了23例化生性乳腺癌,占同期乳腺癌的0.4%,现总结报道如下. 临床资料 1.一般资料:所有患者均为女性,年龄32 ~ 80岁,中位年龄49岁.所有患者均以乳房无痛性肿物收住.病程2d~12个月.除3例为活检术后,其余肿物直径1.5~6 cm,平均3.2cm.据国际抗癌联盟标准,T1 4例,T2 13例,T32例,T41例(系因出现皮肤受侵).有4例可临床触及腋下淋巴结.
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第10期799-800,共2页 Chinese Journal of General Surgery
  • 相关文献

参考文献5

  • 1Tse GM,Tan PH,Putti TC,et al.Metaplastic carcinoma of the breast:a clinicopathological review.J Clin Pathol,2006,59:1079-1083.
  • 2Velasco M,Santamaria G,Ganau S,et al.MRI of metaplastic carcinoma of the breast.Am J Roentgenol,2005,184:1274-1278.
  • 3Seema L,yoeKure K,Lingamfelter D.Challenges to diagnose metaplastic carcinoma of the breast through cytologic methods:an eight-case series.Diagnostic Pathology,2011,6:7.
  • 4Luini A,Aguilar M,Gatti G,et al.Metaplastic carcinoma of the breast,an unusual disease with worse prognosis:the experience of the European Institute of Oncology and review of the literature.Breast Cancer Res Treat,2007,101:349-353.
  • 5于泳,刘君,傅西林,方志沂,只向成.乳腺原发性鳞状细胞癌的临床病理分析[J].中国肿瘤临床,2003,30(3):180-183. 被引量:16

二级参考文献6

  • 1徐大生,吴学如,朱腾方,陈长春.7例原发性乳腺鳞形细胞癌的角蛋白免疫组织化学与雌激素受体检测[J].上海医科大学学报,1989,16(1):11-13. 被引量:3
  • 2王德延.乳腺癌组织学类型与预后的研究[J].肿瘤临床,1985,12:135-135.
  • 3傅西林.病理组织诊断[A].见:中国抗癌协会编.新编常见恶性肿瘤诊治规范:乳腺癌分册[C].中国协和医科大学出版社,1999.219~233.
  • 4姚礼庆 陈福真 何亮家 等.乳腺原发性鳞状细胞癌6例[J].实用外科杂志,1991,11(3):151-151.
  • 5吴祥德 耿翠芝 等.乳腺原发性鳞状细胞癌3例[J].中华肿瘤杂志,1992,14(6):478-478.
  • 6张连郁.乳腺原发性鳞状细胞癌[J].中国肿瘤临床,1985,15(1):49-50. 被引量:6

共引文献15

同被引文献37

  • 1McKinnon E,Xiao P.Metaplastic carcinoma of the breast[J].Arch Pathol Lab Med,2015,139(6):819-822.
  • 2Paul Wright G,Davis AT,Koehler TJ,et al.Hormone receptor status does not affect prognosis in metaplastic breast cancer:a population-based analysis with comparison to infiltrating ductal and lobular carcinomas[J].Ann Surg Oncol,2014,21(11):3497-3503.
  • 3Shah DR,Tseng WH,Martinez SR.Treatment options for metaplastic breast cancer[J].ISRN Oncol,2012,2012:706162.
  • 4Hu Q,Chen WX,Zhong SL,et al.Current progress in the treatment of metaplastic breast carcinoma[J].Asian Pac J Cancer Prev,2013,14(11):6221-6225.
  • 5Luini A,Aguilar M,Gatti G,et al.Metaplastic carcinoma of the breast,an unusual disease with worse prognosis:the experience of the European Institute of Oncology and review of the literature[J].Breast Cancer Res Treat,2007,101(3):349-353.
  • 6Terando AM,Agnese DM,Holmes DR.Treatment and Prognosis of Rare Breast Cancers[J].Ann Surg Oncol,2015,22(10):3225-3229.
  • 7Lakhani SR,Ellis IO,Schnitt SJ,et al.WHO Classification of Tumours of the breast[M].4th ed.Lyon:IARC Press,2012:48-54.
  • 8Nowara E,Drosik A,Samborska-Plewicka M,et al.Metaplastic breast carcinomas-analysis of prognostic factors in a case series[J].Contemp Oncol(Pozn),2014,18(2):116-119.
  • 9Barr JG,Jane Clayton ES,Sotheran W.A case of metaplastic breast cancer in a man[J].J Surg Case Rep,2013,2013(2).dio:10.1093/jscr/rjs047.
  • 10Oon ML,Thike AA,Tan SY,et al.Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast[J].Breast Cancer Res Treat,2015,150(1):31-41.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部